COVID-19 Impact on Global Psoriatic Arthritis Drug Market Size, Status and Forecast 2020-2026

September 2020 | 93 pages | ID: C6B56BDC047BEN
QYResearch

Abstracts

This report focuses on the global Psoriatic Arthritis Drug status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Psoriatic Arthritis Drug development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• Abbvie
• Janssen
• Amgen
• Pfizer
• Eli-lilly
• Celgene

Market segment by Type, the product can be split into

• TNF Inhibitors
• PDE4 Inhibitors
• Interleukin Blockers
• Other

Market segment by Application, split into

• Mild Psoriatic Arthritis
• Moderate Psoriatic Arthritis
• Severe Psoriatic Arthritis

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Psoriatic Arthritis Drug status, future forecast, growth opportunity, key market and key players.
• To present the Psoriatic Arthritis Drug development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Psoriatic Arthritis Drug are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Psoriatic Arthritis Drug Revenue
1.4 Market Analysis by Type
  1.4.1 Global Psoriatic Arthritis Drug Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 TNF Inhibitors
  1.4.3 PDE4 Inhibitors
  1.4.4 Interleukin Blockers
  1.4.5 Other
1.5 Market by Application
  1.5.1 Global Psoriatic Arthritis Drug Market Share by Application: 2020 VS 2026
  1.5.2 Mild Psoriatic Arthritis
  1.5.3 Moderate Psoriatic Arthritis
  1.5.4 Severe Psoriatic Arthritis
1.6 Coronavirus Disease 2019 (Covid-19): Psoriatic Arthritis Drug Industry Impact
  1.6.1 How the Covid-19 is Affecting the Psoriatic Arthritis Drug Industry
    1.6.1.1 Psoriatic Arthritis Drug Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Psoriatic Arthritis Drug Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Psoriatic Arthritis Drug Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Psoriatic Arthritis Drug Market Perspective (2015-2026)
2.2 Psoriatic Arthritis Drug Growth Trends by Regions
  2.2.1 Psoriatic Arthritis Drug Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Psoriatic Arthritis Drug Historic Market Share by Regions (2015-2020)
  2.2.3 Psoriatic Arthritis Drug Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Psoriatic Arthritis Drug Market Growth Strategy
  2.3.6 Primary Interviews with Key Psoriatic Arthritis Drug Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Psoriatic Arthritis Drug Players by Market Size
  3.1.1 Global Top Psoriatic Arthritis Drug Players by Revenue (2015-2020)
  3.1.2 Global Psoriatic Arthritis Drug Revenue Market Share by Players (2015-2020)
  3.1.3 Global Psoriatic Arthritis Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Psoriatic Arthritis Drug Market Concentration Ratio
  3.2.1 Global Psoriatic Arthritis Drug Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Psoriatic Arthritis Drug Revenue in 2019
3.3 Psoriatic Arthritis Drug Key Players Head office and Area Served
3.4 Key Players Psoriatic Arthritis Drug Product Solution and Service
3.5 Date of Enter into Psoriatic Arthritis Drug Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Psoriatic Arthritis Drug Historic Market Size by Type (2015-2020)
4.2 Global Psoriatic Arthritis Drug Forecasted Market Size by Type (2021-2026)

5 PSORIATIC ARTHRITIS DRUG BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Psoriatic Arthritis Drug Market Size by Application (2015-2020)
5.2 Global Psoriatic Arthritis Drug Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Psoriatic Arthritis Drug Market Size (2015-2020)
6.2 Psoriatic Arthritis Drug Key Players in North America (2019-2020)
6.3 North America Psoriatic Arthritis Drug Market Size by Type (2015-2020)
6.4 North America Psoriatic Arthritis Drug Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Psoriatic Arthritis Drug Market Size (2015-2020)
7.2 Psoriatic Arthritis Drug Key Players in Europe (2019-2020)
7.3 Europe Psoriatic Arthritis Drug Market Size by Type (2015-2020)
7.4 Europe Psoriatic Arthritis Drug Market Size by Application (2015-2020)

8 CHINA

8.1 China Psoriatic Arthritis Drug Market Size (2015-2020)
8.2 Psoriatic Arthritis Drug Key Players in China (2019-2020)
8.3 China Psoriatic Arthritis Drug Market Size by Type (2015-2020)
8.4 China Psoriatic Arthritis Drug Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Psoriatic Arthritis Drug Market Size (2015-2020)
9.2 Psoriatic Arthritis Drug Key Players in Japan (2019-2020)
9.3 Japan Psoriatic Arthritis Drug Market Size by Type (2015-2020)
9.4 Japan Psoriatic Arthritis Drug Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Psoriatic Arthritis Drug Market Size (2015-2020)
10.2 Psoriatic Arthritis Drug Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Psoriatic Arthritis Drug Market Size by Type (2015-2020)
10.4 Southeast Asia Psoriatic Arthritis Drug Market Size by Application (2015-2020)

11 INDIA

11.1 India Psoriatic Arthritis Drug Market Size (2015-2020)
11.2 Psoriatic Arthritis Drug Key Players in India (2019-2020)
11.3 India Psoriatic Arthritis Drug Market Size by Type (2015-2020)
11.4 India Psoriatic Arthritis Drug Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Psoriatic Arthritis Drug Market Size (2015-2020)
12.2 Psoriatic Arthritis Drug Key Players in Central & South America (2019-2020)
12.3 Central & South America Psoriatic Arthritis Drug Market Size by Type (2015-2020)
12.4 Central & South America Psoriatic Arthritis Drug Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Abbvie
  13.1.1 Abbvie Company Details
  13.1.2 Abbvie Business Overview and Its Total Revenue
  13.1.3 Abbvie Psoriatic Arthritis Drug Introduction
  13.1.4 Abbvie Revenue in Psoriatic Arthritis Drug Business (2015-2020))
  13.1.5 Abbvie Recent Development
13.2 Janssen
  13.2.1 Janssen Company Details
  13.2.2 Janssen Business Overview and Its Total Revenue
  13.2.3 Janssen Psoriatic Arthritis Drug Introduction
  13.2.4 Janssen Revenue in Psoriatic Arthritis Drug Business (2015-2020)
  13.2.5 Janssen Recent Development
13.3 Amgen
  13.3.1 Amgen Company Details
  13.3.2 Amgen Business Overview and Its Total Revenue
  13.3.3 Amgen Psoriatic Arthritis Drug Introduction
  13.3.4 Amgen Revenue in Psoriatic Arthritis Drug Business (2015-2020)
  13.3.5 Amgen Recent Development
13.4 Pfizer
  13.4.1 Pfizer Company Details
  13.4.2 Pfizer Business Overview and Its Total Revenue
  13.4.3 Pfizer Psoriatic Arthritis Drug Introduction
  13.4.4 Pfizer Revenue in Psoriatic Arthritis Drug Business (2015-2020)
  13.4.5 Pfizer Recent Development
13.5 Eli-lilly
  13.5.1 Eli-lilly Company Details
  13.5.2 Eli-lilly Business Overview and Its Total Revenue
  13.5.3 Eli-lilly Psoriatic Arthritis Drug Introduction
  13.5.4 Eli-lilly Revenue in Psoriatic Arthritis Drug Business (2015-2020)
  13.5.5 Eli-lilly Recent Development
13.6 Celgene
  13.6.1 Celgene Company Details
  13.6.2 Celgene Business Overview and Its Total Revenue
  13.6.3 Celgene Psoriatic Arthritis Drug Introduction
  13.6.4 Celgene Revenue in Psoriatic Arthritis Drug Business (2015-2020)
  13.6.5 Celgene Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Psoriatic Arthritis Drug Key Market Segments
Table 2. Key Players Covered: Ranking by Psoriatic Arthritis Drug Revenue
Table 3. Ranking of Global Top Psoriatic Arthritis Drug Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Psoriatic Arthritis Drug Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of TNF Inhibitors
Table 6. Key Players of PDE4 Inhibitors
Table 7. Key Players of Interleukin Blockers
Table 8. Key Players of Other
Table 9. COVID-19 Impact Global Market: (Four Psoriatic Arthritis Drug Market Size Forecast Scenarios)
Table 10. Opportunities and Trends for Psoriatic Arthritis Drug Players in the COVID-19 Landscape
Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 12. Key Regions/Countries Measures against Covid-19 Impact
Table 13. Proposal for Psoriatic Arthritis Drug Players to Combat Covid-19 Impact
Table 14. Global Psoriatic Arthritis Drug Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 15. Global Psoriatic Arthritis Drug Market Size by Regions (US$ Million): 2020 VS 2026
Table 16. Global Psoriatic Arthritis Drug Market Size by Regions (2015-2020) (US$ Million)
Table 17. Global Psoriatic Arthritis Drug Market Share by Regions (2015-2020)
Table 18. Global Psoriatic Arthritis Drug Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 19. Global Psoriatic Arthritis Drug Market Share by Regions (2021-2026)
Table 20. Market Top Trends
Table 21. Key Drivers: Impact Analysis
Table 22. Key Challenges
Table 23. Psoriatic Arthritis Drug Market Growth Strategy
Table 24. Main Points Interviewed from Key Psoriatic Arthritis Drug Players
Table 25. Global Psoriatic Arthritis Drug Revenue by Players (2015-2020) (Million US$)
Table 26. Global Psoriatic Arthritis Drug Market Share by Players (2015-2020)
Table 27. Global Top Psoriatic Arthritis Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Psoriatic Arthritis Drug as of 2019)
Table 28. Global Psoriatic Arthritis Drug by Players Market Concentration Ratio (CR5 and HHI)
Table 29. Key Players Headquarters and Area Served
Table 30. Key Players Psoriatic Arthritis Drug Product Solution and Service
Table 31. Date of Enter into Psoriatic Arthritis Drug Market
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Psoriatic Arthritis Drug Market Size by Type (2015-2020) (Million US$)
Table 34. Global Psoriatic Arthritis Drug Market Size Share by Type (2015-2020)
Table 35. Global Psoriatic Arthritis Drug Revenue Market Share by Type (2021-2026)
Table 36. Global Psoriatic Arthritis Drug Market Size Share by Application (2015-2020)
Table 37. Global Psoriatic Arthritis Drug Market Size by Application (2015-2020) (Million US$)
Table 38. Global Psoriatic Arthritis Drug Market Size Share by Application (2021-2026)
Table 39. North America Key Players Psoriatic Arthritis Drug Revenue (2019-2020) (Million US$)
Table 40. North America Key Players Psoriatic Arthritis Drug Market Share (2019-2020)
Table 41. North America Psoriatic Arthritis Drug Market Size by Type (2015-2020) (Million US$)
Table 42. North America Psoriatic Arthritis Drug Market Share by Type (2015-2020)
Table 43. North America Psoriatic Arthritis Drug Market Size by Application (2015-2020) (Million US$)
Table 44. North America Psoriatic Arthritis Drug Market Share by Application (2015-2020)
Table 45. Europe Key Players Psoriatic Arthritis Drug Revenue (2019-2020) (Million US$)
Table 46. Europe Key Players Psoriatic Arthritis Drug Market Share (2019-2020)
Table 47. Europe Psoriatic Arthritis Drug Market Size by Type (2015-2020) (Million US$)
Table 48. Europe Psoriatic Arthritis Drug Market Share by Type (2015-2020)
Table 49. Europe Psoriatic Arthritis Drug Market Size by Application (2015-2020) (Million US$)
Table 50. Europe Psoriatic Arthritis Drug Market Share by Application (2015-2020)
Table 51. China Key Players Psoriatic Arthritis Drug Revenue (2019-2020) (Million US$)
Table 52. China Key Players Psoriatic Arthritis Drug Market Share (2019-2020)
Table 53. China Psoriatic Arthritis Drug Market Size by Type (2015-2020) (Million US$)
Table 54. China Psoriatic Arthritis Drug Market Share by Type (2015-2020)
Table 55. China Psoriatic Arthritis Drug Market Size by Application (2015-2020) (Million US$)
Table 56. China Psoriatic Arthritis Drug Market Share by Application (2015-2020)
Table 57. Japan Key Players Psoriatic Arthritis Drug Revenue (2019-2020) (Million US$)
Table 58. Japan Key Players Psoriatic Arthritis Drug Market Share (2019-2020)
Table 59. Japan Psoriatic Arthritis Drug Market Size by Type (2015-2020) (Million US$)
Table 60. Japan Psoriatic Arthritis Drug Market Share by Type (2015-2020)
Table 61. Japan Psoriatic Arthritis Drug Market Size by Application (2015-2020) (Million US$)
Table 62. Japan Psoriatic Arthritis Drug Market Share by Application (2015-2020)
Table 63. Southeast Asia Key Players Psoriatic Arthritis Drug Revenue (2019-2020) (Million US$)
Table 64. Southeast Asia Key Players Psoriatic Arthritis Drug Market Share (2019-2020)
Table 65. Southeast Asia Psoriatic Arthritis Drug Market Size by Type (2015-2020) (Million US$)
Table 66. Southeast Asia Psoriatic Arthritis Drug Market Share by Type (2015-2020)
Table 67. Southeast Asia Psoriatic Arthritis Drug Market Size by Application (2015-2020) (Million US$)
Table 68. Southeast Asia Psoriatic Arthritis Drug Market Share by Application (2015-2020)
Table 69. India Key Players Psoriatic Arthritis Drug Revenue (2019-2020) (Million US$)
Table 70. India Key Players Psoriatic Arthritis Drug Market Share (2019-2020)
Table 71. India Psoriatic Arthritis Drug Market Size by Type (2015-2020) (Million US$)
Table 72. India Psoriatic Arthritis Drug Market Share by Type (2015-2020)
Table 73. India Psoriatic Arthritis Drug Market Size by Application (2015-2020) (Million US$)
Table 74. India Psoriatic Arthritis Drug Market Share by Application (2015-2020)
Table 75. Central & South America Key Players Psoriatic Arthritis Drug Revenue (2019-2020) (Million US$)
Table 76. Central & South America Key Players Psoriatic Arthritis Drug Market Share (2019-2020)
Table 77. Central & South America Psoriatic Arthritis Drug Market Size by Type (2015-2020) (Million US$)
Table 78. Central & South America Psoriatic Arthritis Drug Market Share by Type (2015-2020)
Table 79. Central & South America Psoriatic Arthritis Drug Market Size by Application (2015-2020) (Million US$)
Table 80. Central & South America Psoriatic Arthritis Drug Market Share by Application (2015-2020)
Table 81. Abbvie Company Details
Table 82. Abbvie Business Overview
Table 83. Abbvie Product
Table 84. Abbvie Revenue in Psoriatic Arthritis Drug Business (2015-2020) (Million US$)
Table 85. Abbvie Recent Development
Table 86. Janssen Company Details
Table 87. Janssen Business Overview
Table 88. Janssen Product
Table 89. Janssen Revenue in Psoriatic Arthritis Drug Business (2015-2020) (Million US$)
Table 90. Janssen Recent Development
Table 91. Amgen Company Details
Table 92. Amgen Business Overview
Table 93. Amgen Product
Table 94. Amgen Revenue in Psoriatic Arthritis Drug Business (2015-2020) (Million US$)
Table 95. Amgen Recent Development
Table 96. Pfizer Company Details
Table 97. Pfizer Business Overview
Table 98. Pfizer Product
Table 99. Pfizer Revenue in Psoriatic Arthritis Drug Business (2015-2020) (Million US$)
Table 100. Pfizer Recent Development
Table 101. Eli-lilly Company Details
Table 102. Eli-lilly Business Overview
Table 103. Eli-lilly Product
Table 104. Eli-lilly Revenue in Psoriatic Arthritis Drug Business (2015-2020) (Million US$)
Table 105. Eli-lilly Recent Development
Table 106. Celgene Company Details
Table 107. Celgene Business Overview
Table 108. Celgene Product
Table 109. Celgene Revenue in Psoriatic Arthritis Drug Business (2015-2020) (Million US$)
Table 110. Celgene Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Psoriatic Arthritis Drug Market Share by Type: 2020 VS 2026
Figure 2. TNF Inhibitors Features
Figure 3. PDE4 Inhibitors Features
Figure 4. Interleukin Blockers Features
Figure 5. Other Features
Figure 6. Global Psoriatic Arthritis Drug Market Share by Application: 2020 VS 2026
Figure 7. Mild Psoriatic Arthritis Case Studies
Figure 8. Moderate Psoriatic Arthritis Case Studies
Figure 9. Severe Psoriatic Arthritis Case Studies
Figure 10. Psoriatic Arthritis Drug Report Years Considered
Figure 11. Global Psoriatic Arthritis Drug Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Psoriatic Arthritis Drug Market Share by Regions: 2020 VS 2026
Figure 13. Global Psoriatic Arthritis Drug Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Psoriatic Arthritis Drug Market Share by Players in 2019
Figure 16. Global Top Psoriatic Arthritis Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Psoriatic Arthritis Drug as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Psoriatic Arthritis Drug Revenue in 2019
Figure 18. North America Psoriatic Arthritis Drug Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Psoriatic Arthritis Drug Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Psoriatic Arthritis Drug Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Psoriatic Arthritis Drug Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Psoriatic Arthritis Drug Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Psoriatic Arthritis Drug Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Psoriatic Arthritis Drug Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Abbvie Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Abbvie Revenue Growth Rate in Psoriatic Arthritis Drug Business (2015-2020)
Figure 27. Janssen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Janssen Revenue Growth Rate in Psoriatic Arthritis Drug Business (2015-2020)
Figure 29. Amgen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Amgen Revenue Growth Rate in Psoriatic Arthritis Drug Business (2015-2020)
Figure 31. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Pfizer Revenue Growth Rate in Psoriatic Arthritis Drug Business (2015-2020)
Figure 33. Eli-lilly Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Eli-lilly Revenue Growth Rate in Psoriatic Arthritis Drug Business (2015-2020)
Figure 35. Celgene Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Celgene Revenue Growth Rate in Psoriatic Arthritis Drug Business (2015-2020)
Figure 37. Bottom-up and Top-down Approaches for This Report
Figure 38. Data Triangulation
Figure 39. Key Executives Interviewed